Medivation

BioMarin sells its PhIII cancer drug to Medivation for $570M
Fierce Biotech
Mon, 08/24/15 - 11:22 am
Biomarin
Medivation
talazoparib
breast cancer
BRCA1
BRCA2
Why Shares in Medivation Inc. Tumbled Over 10% in June
Motley Fool
Sun, 07/12/15 - 09:34 am
Medivation
Xtandi
prostate cancer
3 Biotech Stocks That Could Grow Faster than Apple
Motley Fool
Sun, 07/5/15 - 11:00 am
biotech
Celgene
Medivation
Ligand Pharmaceuticals
Astellas, Medivation to amp up unbranded Xtandi marketing for pre-chemo use
Fierce Pharma Marketing
Wed, 06/17/15 - 10:24 am
Astellas
Medivation
Xtandi
drug marketing
prostate cancer
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Fierce Pharma Marketing
Wed, 05/20/15 - 06:15 pm
Medivation
Xtandi
Astellas
JNJ
Zytiga
Chugai Pharma Appears To Own U.S., Japan And EU Patent Rights To Medivation's Xtandi
Seeking Alpha
Tue, 05/12/15 - 04:29 pm
Chugai
Medivation
Xtandi
patents
Japan
Europe
Medivation reports 1Q loss
Yahoo/AP
Mon, 05/11/15 - 10:59 am
Medivation
earnings
4 Pharmaceutical Companies Leading the Breast Cancer Fight
24/7 Wall St
Fri, 05/8/15 - 10:48 am
breast cancer
Merck
Bristol-Myers Squibb
Medivation
Pfizer
Medivation's Xtandi Beats Casodex In Cancer Trial
Investors.com
Fri, 04/3/15 - 08:38 am
Medivation
Xtandi
Casodex
Astellas
prostate cancer
Best One-Drug Wonder Stock for 2015
Motley Fool
Mon, 03/23/15 - 09:10 am
Orexigen
Medivation
Isis Pharmaceuticals
Will Medivation Kick J&J To The Curb For This $9 Billion Market?
Seeking Alpha
Wed, 03/4/15 - 09:46 am
JNJ
Medivation
Xtandi
Medivation beats Street 4Q forecasts
Yahoo/AP
Thu, 02/26/15 - 09:49 am
Medivation
earnings
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Seeking Alpha
Wed, 12/17/14 - 08:53 am
Medivation
Xtandi
triple negative breast cancer
breast cancer
Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer
Yahoo/MarketWired
Sat, 12/13/14 - 11:26 am
Enzalutamide
Medivation
Astellas
breast cancer
Newly Profitable Medivation Riding High On Drug Sales
Investors.com
Sat, 11/29/14 - 10:28 am
Medivation
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wed, 11/12/14 - 08:41 am
JNJ
Medivation
M&A
Xtandi
prostate cancer
Medivation Hits High After Q3 Earnings Beat
Investors.com
Fri, 11/7/14 - 12:29 pm
Medivation
earnings
Strong Prostate Cancer Drug Sales Will Help Medivation Expand Pipeline
TheStreet.com
Wed, 11/5/14 - 08:07 am
prostate cancer
Medivation
Xtandi
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Motley Fool
Mon, 10/27/14 - 08:10 am
biotech
Gilead Sciences
Medivation
Astellas
Celgene
Biogen Idec
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas

Pages